LENZ ROBERT A. (Head of R&D) sold 1.8% of their position (5.61K shares) of NEUMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2025ACC: 0001610717-25-000028
Officer· Head of R&D
Since Sep 2023
-5.61K
Net shares
Net seller
$9.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.61K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.61K
Price / share
$1.67
Trade value
$9.38K
% of position
1.8%
2/18/2025
314.71K→309.09K
Total
Net shares
−5.61K
Net value
-$9.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2025 | S · Sale | −5.61K | $1.67 | $9.38K | 1.8% | 314.71K | 309.09K |
| Total | −5.61K | -$9.38K | ||||||
Derivative Transactions0
No derivative transactions reported